Aedes aegypti (Ae. aegypti) is one of the most important vectors of dengue, chikungunya and yellow fever viruses. The use of chemical control strategies such as insecticides is associated with problems including the development of insecticide resistance, side effects on animal and human health, and environmental concerns. Because current methods have not proven sufficient to control these diseases, developing novel, genetics-based, control strategies to limit the transmission of disease is urgently needed. Increased knowledge about mosquito-pathogen relationships and the molecular biology of mosquitoes now makes it possible to generate transgenic mosquito strains that are unable to transmit various parasites or viruses. Ae. aegypti genetic experiments are enabled, and limited by, the catalog of promoter elements available to drive transgene expression. To find a promoter able to drive robust expression of firefly (FF) luciferase in Ae. aegypti embryos, an experiment was designed to compare Ae. aegypti endogenous and exogenous promoters. The PUb promoter was found to be extremely robust in expression of FF luciferase in different stages of embryonic development from 2-72 hours after injection. In subsequent experiments, transformation frequency was calculated using four different promoters (IE1, UbL40, hsp82 and PUb) to express the Mos1 transposase open reading frame in Mos1-mediated transgenesis. Germline transformation efficiency and size of transgenic cluster were not significantly different when using endogenous Ae. aegypti PUb or the commonly used exogenous Drosophila hsp82 promoter to express Mos1 transposase. This study also describes the development of new tools for gene editing in the Ae. aegypti mosquito genome and the use of these tools to design an efficient gene drive system in this mosquito. Homing endonucleases (HEs) are selfish elements which catalyze double-stranded DNA (dsDNA) breaks in a sequence-specific manner. The activities of four HEs (Y2-I-AniI, I-CreI, I-PpoI, and I-SceI) were investigated for their ability to catalyze the excision of genomic segments from the Ae. aegypti genome. All four enzymes were found to be active in Ae. aegypti; however, the activity of Y2-I-AniI was higher compared to the other three enzymes. Single-strand annealing (SSA) and non-homologous end-joining (NHEJ) pathways were identified as mechanisms to repair HE-induced dsDNA breaks. TALE nucleases (TALENs) are a group of artificial enzymes capable of generating site-specific DNA lesions. To examine the ability of TALENs for gene editing in Ae. aegypti, a pair of TALENs targeted to the kmo gene were expressed from a plasmid following embryonic injection. Twenty to forty percent of fertile G0 produced white-eyed progeny which resulted from disruption of the kmo gene. Most of these individuals produced more than 20% white-eyed progeny, with some producing up to 75%. A small deletion of one to seven bp occurred at the TALEN recognition site. These results show that TALEN and HEs are highly active in the Ae. aegypti germline and can be used for gene editing and gene drive strategies in Ae. aegypti. / Ph. D.

Mosquitoes are notorious vectors for multiple diseases like malaria, yellow fever and dengue fever. To manipulate gene expression in mosquito and spread desired genes among natural population for vector control, a thorough understanding of mosquito development and gene regulation is critical. Early embryogenesis is a rapid, complex yet crucial process in the very beginning of development. Previous research in other species indicated genes transcribed that early evolved fast and played essential roles. The study of mosquito early zygotic genes (EZGs) would offer unique insights into mosquito gene evolution as well as potential targets for mosquito control. In this study, I identified 61 pure EZGs (pEZGs) in mosquito Aedes aegypti. These pEZGs were enriched in architectures adapting to the rapid embryonic cell cycles and were over represented by domains or functions related to maternal zygotic transition. Phylogenetic analysis showed that pEZGs originated mainly from duplication, retrotransposition and de novo emergence. The comparison of pEZGs in Ae. aegypti with those in Drosophila revealed an interesting evolutionary paradox where the early zygotic genes turned over fast but the regulatory motif was conserved in two species. Curiously, the motif binding protein in Drosophila (zelda) seemed unable to initiate the earliest zygotic transcription in Ae. aegypti due to late temporal expression. The regulatory motif (VBRGGTA) found in Ae. aegypti pEZGs was shown necessary and sufficient for driving early zygotic gene expression by transient reporter assays and one motif-bearing promoter was tested with success in driving gene expression as early as 2-4h after egg laying in transgenic Ae. aegypti. This was the first characterized promoter with early zygotic but no maternal expression in Ae. aegypti that can be used for future genetic studies and mosquito control strategies. As important gene regulators, miRNAs also play essential roles in early embryogenesis. The genome-wide predictions and systematic analysis of miRNAs in Ae. aegypti and Anopheles stephensi were conducted in this study. The first miRNA profiling in mosquito across all developmental stages was also performed to provide basis for future functional study. Several lineage-specific miRNAs were found highly expressed in embryos, indicating their special roles in the embryogenesis of mosquitoes. / Ph. D.

Malaria ist eine Krankheit, die durch den Protozoen Plasmodium verursacht und von Anopheles Moskitos durch infektiöse Stiche übertragen wird. Diese ̈Übertragung kann durch verschiedene Interventionsstrategien blockiert werden. Eine relativ neue Strategie, die bisher nur im Labor getestet wurde, ist der Einsatz genetisch veränderter Moskitos, die den Parasiten nicht auf einen neuen menschlichen Wirt übertragen können. Ein Ansatz ist die Entwicklung von Moskitos, die mit murinen Antikoepern ausgestattet sind, die gegen relevante Oberflächenproteine des Parasiten, dem Circumsporozoite Protein (CSP) gerichtet sind. Es ist jedoch nach wie vor unklar, welches Entwicklungsstadium angegriffen werden soll und welche Antikörper für diesen Ansatz effizient sind. Hier zeige ich, dass in Stechmücken, die mit einem humanen Anti-CSP-Antikörper ausgestattet sind, die Sporogonie der Oozysten in Abhängigkeit von der Parasiten-dichte blockiert wird und somit die Sporozoitenlast in den Mücken signifikant verringern. Insbesondere Antikörper, die sich an die ’Repeat Region’ des CSP binden, können die Sporozoitenlast in der Stechmücke verringern. Des Weitern, zeigen diese Stechmücken kaum Defekte in der Entwicklung und im Überleben. Diese Ergebnisse bestätigen die zuvor beschriebene Bedeutung von CSP während der Sporogonie und unterstreichen die Effizienz von humanen, ’Repeat Region’ bindenden Anti-CSP-Antikörpern bei der Beeinträchtigung der Parasitenentwicklung in dem Vektor. Darüber hinaus ist in Stechmücken, die mit humanen Anti-CSP Antikörpern ausgestattet sind, die Entwicklung von Sporozoiten teils limitiert und teils komplett verhindert. Dies macht sie zu einem vielversprechenden Instrument für Maßnahmen zum Malaria Kontrolle. In dieser Arbeit habe ich weitere Einblicke in den Mechanismus , durch den Anti-CSP-Antikörper die Parasitenentwicklung in der Mücke stören, und gezeigt, dass Oozysten ein effizientes Ziel für diesen Ansatz sind. / Malaria is a disease caused by the protozoan parasite Plasmodium and transmitted by Anopheles mosquitoes trough infectious bites, these transmission events can potentially be blocked by different intervention strategies. A relatively new strategy which has been only tested in the laboratory is the use of genetically modified mosquitoes unable to transmit the parasite to a new human host. In the past, murine derived antibodies directed against relevant parasite surface proteins were used with limited success. It remains unclear which developmental stage is targeted, and which antibodies are useful. Here, I show that in mosquitoes equipped with a human derived anti-CSP repeat binding antibody, oocyst sporogony is blocked in a parasite density dependent manner. Only repeat binding antibodies could decrease sporozoite loads in the mosquito. These results confirm the previously described importance of CSP during sporogony and highlight the efficiency of human derived repeat binding anti-CSP antibodies in interfering with parasite development even in a different host. Additionally, mosquitoes equipped with human derived anti-CSP antibodies show little (in high density infections) to no (in low density infections) sporogonic development, making them a promising tool for malaria transmission blocking interventions. I provided additional insights into the mechanism by which anti-CSP antibodies interfere with parasite development in the mosquito showing that oocysts are an efficient target for this approach. Therefore, the mosquitoes used here are potentially resistant in a more natural setting. Additionally, I provided a new tool allowing a faster screening of antibodies in a mosquito context by injection of single chain Fabs into the mosquito hemolymph. Taken together, this approach could one day give rise to alternative strategies in tackling malaria transmissions.